About: beractant

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: beractant Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

mixture

Attributes	Values
rdf:type	Item
owl:sameAs	beractant
description	mixture (en) mieszanina (pl) ଏହା ଏକ ଔଷଧ ଯାହା ନବଜାତ ଶିଶୁମାନଙ୍କଠାରେ ଶ୍ୱାସକ୍ରିୟାର ଅସୁବିଧାକୁ (ରେସ୍ପିରେଟୋରୀ ଡିଷ୍ଟ୍ରେସ ସିଣ୍ଡ୍ରୋମ) ରୋକିବା ଏବଂ ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ । (or)
rdfs:label	beractant (en) beractanto (pt) beraktant (pl) beraktant (sl) برکتانت (fa) ବେରାକ୍ଟାଣ୍ଟ (hi)
skos:prefLabel	beractant (en) beractanto (pt) beraktant (pl) beraktant (sl) برکتانت (fa) ବେରାକ୍ଟାଣ୍ଟ (hi)
name	beractant (en) beractanto (pt) beraktant (pl) beraktant (sl) برکتانت (fa) ବେରାକ୍ଟାଣ୍ଟ (hi)
subject has role	wds:Q4890968-5937E672-303B-4B0E-B83D-647F1B90B024
Freebase ID	wds:Q4890968-36EDCFFD-1770-4EEF-9FED-53F3CE04132E
subject has role	pulmonary surfactant
Freebase ID	/m/0hqvgq0
instance of	wds:Q4890968-285db04c-56a4-454a-9635-4aa604770f22 wds:Q4890968-f77fa53a-4693-7ef2-2490-ab6485370689
instance of	mixture medication
NDF-RT ID	wds:Q4890968-5286A196-0F49-485C-8678-A8C98954E1D1
CAS Registry Number	wds:Q4890968-94869361-E0D4-4DC6-BAFD-5EBE904AD8ED
DSSTox substance ID	wds:Q4890968-C24B509F-A7C7-4A30-B3C7-C5B2060072D5
RxNorm ID	wds:Q4890968-D4703A00-1599-4EDA-9D5C-3A8A4890B6C4
UNII	wds:Q4890968-9BEFC195-E527-4F0B-BC93-3CEB4E13CEB1
DrugBank ID	wds:Q4890968-C46DED26-81BD-44D7-B8A6-36ADCCDA45C6
NDF-RT ID	http://purl.bioontology.org/ontology/NDFRT/N0000148076
NDF-RT ID	N0000148076
CAS Registry Number	108778-82-1
DSSTox substance ID	DTXSID70883180
RxNorm ID	46967
UNII	S866O45PIG
DrugBank ID	06761
medical condition treated	wds:Q4890968-34A5CEB6-ECE5-419A-888D-FF8CB1994276
ChEMBL ID	wds:Q4890968-69D77FB1-4D01-4E51-A560-1CFDB9EE10ED
ChEMBL ID	http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201624
medical condition treated	acute respiratory distress syndrome
ChEMBL ID	CHEMBL1201624
skos:altLabel	Survanta (en)
NCI Thesaurus ID	wds:Q4890968-6ACF3BF4-F1F9-47B4-A4CF-3D2928846838
UMLS CUI	wds:Q4890968-93ACEAC5-795A-42F8-8CEE-3668F3965DEC
MeSH descriptor ID	wds:Q4890968-CC9BBDB7-0BAC-488F-9108-C9DD9FE66C63
Microsoft Academic ID	wds:Q4890968-08C7D679-59D4-409C-A69C-C7A88395E30B
MeSH descriptor ID	http://id.nlm.nih.gov/mesh/C072197
Microsoft Academic ID	https://makg.org/entity/2778297618
NCI Thesaurus ID	C81354
UMLS CUI	C0105750
MeSH descriptor ID	C072197
Microsoft Academic ID	2778297618
WikiProjectMed ID	wds:Q4890968-02D54576-C555-4E9F-AC81-715A9544C604
WikiProjectMed ID	Beractant
active ingredient in	wds:Q4890968-0CF20308-4B93-42E9-BB2B-A2A4858A2E88
active ingredient in	Survanta
is owl:sameAs of	beractant
is about of	beractant https://www.wikidata.org/wiki/Special:EntityData/Q4890968 Beractant https://or.wikipedia.org/wiki/%E0%AC%AC%E0%AD%87%E0%AC%B0%E0%AC%BE%E0%AC%95%E0%AD%8D%E0%AC%9F%E0%AC%BE%E0%AC%A3%E0%AD%8D%E0%AC%9F https://fa.wikipedia.org/wiki/%D8%A8%D8%B1%DA%A9%D8%AA%D8%A7%D9%86%D8%AA https://pt.wikipedia.org/wiki/Beractanto
is drug or therapy used for treatment of	acute respiratory distress syndrome
is drug or therapy used for treatment of	wds:Q344873-F8E042B1-1631-462F-B11D-0AB898713573
is main subject of	Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome Neurodevelopmental outcomes of very low birth weight preterm infants treated with poractant alfa versus beractant for respiratory distress syndrome A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Randomized trial comparing two natural surfactants (Survanta vs. bLES) for treatment of neonatal respiratory distress syndrome. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome Complications among premature neonates treated with beractant and poractant alfa Cost effectiveness of beractant in the prevention of respiratory distress syndrome Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity Characterization of surfactant subtypes of beractant and a synthetic peptide containing surfactant KL4 following surface area cycling and addition of fibrinogen Failure to detect surfactant protein-specific antibodies in sera of premature infants treated with survanta, a modified bovine surfactant Interactions of poly(amidoamine) dendrimers with Survanta lung surfactant: the importance of lipid domains Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group Spiking Survanta with synthetic surfactant peptides improves oxygenation in surfactant-deficient rats Treatment Investigational New Drug experience with Survanta (beractant). A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4. Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome Less invasive beractant administration in preterm infants: a pilot study.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software